Posted in

Director Quantitative Pharmacology

Director Quantitative Pharmacology

CompanyRegeneron Pharmaceuticals
LocationCambridge, MA, USA, Berkeley Heights, NJ, USA, Tarrytown, NY, USA
Salary$202000 – $336600
TypeFull-Time
DegreesPhD
Experience LevelExpert or higher

Requirements

  • PhD +8 years with a degree in Quantitative Pharmacology (pharmacometrics) or related field
  • Hands on usage of a broad range of quantitative tools and systems is required
  • Strong publication record in the field
  • Excellent interpersonal and communication skills, both written and oral
  • Ability to communicate complex information succinctly
  • Proven experience developing QP elements of regulatory strategy and interacting with regulatory agencies without supervision

Responsibilities

  • Manages and is accountable for the PK/PD evaluation of a small portfolio of products or projects
  • Works independently, with guidance in only the most complex situations
  • Informs PMx management of important program and regulatory developments in a timely manner
  • Ensures analyses and documentation are of the highest quality and accuracy
  • Ensures that reports and other documents have the appropriate messaging and that a meaningful ‘story-line’ is developed
  • Ensures that study reports and other documents have an appropriate functional review and are suitable for review by senior management
  • Solves complex problems; takes a broad perspective to identify solutions
  • Makes contributions to multi-disciplinary meetings by sharing cross-functional skills and knowledge

Preferred Qualifications

  • Fully knowledgeable of pharmacokinetic/pharmacodynamic principles, pharmacology, biology, and quantitative aspects of drug development
  • Deep understanding of scientific literature and technical skills in a number of PK/PD methods and techniques
  • Extensive knowledge base of the work in overall scientific community in own discipline
  • Recognized as an expert in own area within the organization
  • Extensive regulatory experience through authoring of regulatory briefing books, CTD summaries, contribution at HA meetings, HA negotiations through regulatory reviews and approvals of BLA or equivalent